Canopy Growth (TSX:WEED) CEO Ousted: Is the Stock Still a Buy?

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is reeling from the unexpected termination of Bruce Linton. The stock lost so much power, which is a telling sign that investors should hold off on buying WEED.

| More on:
question marks written reminders tickets

Image source: Getty Images

The departure of the embattled Bruce Linton from Canopy Growth (TSX:WEED)(NYSE:CGC) on July 3 seems to be hurting the largest cannabis company in the world. The company’s founder was mainly responsible for Canopy’s growth for the past six years. Today, there’s doubt as to whether investors should still buy WEED.

Linton left the company with 5.6 million square feet of cultivation capacity in 10 sites. He also obtained the licence from Health Canada for the more than 4.8 million square feet.

Overall, Linton did a superb job of priming Canopy Growth for massive production. But his dreams of making the company the industry stalwart were shattered. The Constellation Brands-dominated board decided to kick Linton out.

Stock performance

The day after Linton stepped down, WEED dropped by 0.84% to $53.07. As of July 12, the price has gone down by 16% to $44.58. The same thing happened on the NYSE, as the stock pointed downward.

There are mixed reactions on the firing of the rock star in the cannabis space. Some are saying it’s good for the company with kind words for Linton. The former CEO didn’t do significant damage except that the biggest investor became too impatient.

Others think Linton’s plans were great but the spending was excessive, and so is the bleeding on the bottom line. The Corona-beer maker was extremely worried about the escalating losses that were impacting heavily on its operating results.

Thus, Constellation Brands had to no choice but to appoint co-CEO Mark Zekulin as the interim chief executive. A new CEO will come by December.

New direction

According to management, the replacement should have international experience and ideally a strong background in pharmaceuticals. The person would be tasked to improve market share and penetrate new markets or create new business segments.

But the pressure is on. Canopy Growth’s net losses have ballooned by 1,204% in 2018. The next-CEO should be able to turn the company around. In the meantime, expenses need to be curtailed including cutting down on marketing expenses.

The focus moving forward will be on profitability. Canopy Growth is expected to turn in profits by 2021 but not any time sooner. Maybe the company really needs a fresh start.

As for Bruce Linton, we won’t see him move to another cannabis producer. He had a non-compete clause in his employment arrangement with Canopy Growth. Linton would’ve be an asset and leader in industry rivals in need of a visionary.

Hold the purchase

Canopy Growth just dropped the industry leader tag with the abrupt exit of Bruce Linton. The race is wide open, and a company not named Canopy Growth might assume the leadership role.

I’m sure the company will survive this setback and perhaps come out stronger. But until it’s headless, it is highly doubtful if the price level can be maintained. The time to invest in Canopy Growth will come. But it’s not today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »